Security National Bank of Sioux City Iowa IA reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,265 shares of the financial services provider’s stock after selling 97 shares during the period. Security National Bank of Sioux City Iowa IA’s holdings in iShares Biotechnology ETF were worth $1,272,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the company. Future Financial Wealth Managment LLC acquired a new position in iShares Biotechnology ETF in the first quarter valued at approximately $27,000. Bbjs Financial Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at $31,000. Pacifica Partners Inc. grew its position in shares of iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after buying an additional 130 shares during the last quarter. YHB Investment Advisors Inc. acquired a new stake in iShares Biotechnology ETF during the 1st quarter worth $37,000. Finally, Mather Group LLC. purchased a new stake in iShares Biotechnology ETF in the first quarter valued at $57,000. 62.45% of the stock is owned by hedge funds and other institutional investors.
iShares Biotechnology ETF Stock Up 0.5 %
Shares of IBB stock opened at $144.90 on Friday. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $150.57. The stock’s 50-day moving average is $145.70 and its two-hundred day moving average is $138.83.
iShares Biotechnology ETF Dividend Announcement
About iShares Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Read More
- Five stocks we like better than iShares Biotechnology ETF
- What is the S&P 500 and How It is Distinct from Other Indexes
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- Industrial Products Stocks Investing
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- ETF Screener: Uses and Step-by-Step Guide
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.